AP
ABVX icon

Andera Partners’s Abivax ABVX Stock Holding History

Andera Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-78,125
Closed -$10.4M – 8
2026
Q2 		$10.4M Hold
78,125
– – 5.04% 7
2026
Q1 		$8.7M Hold
78,125
– – 4.92% 6
2025
Q4 		$10.5M Buy
+78,125
New +$8.52M 5.97% 4

Other funds holding ABVX

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
FIA
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
CRI
Colonial River Investments Midlothian, Virginia $387M AUM 30.41% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.73% 1-Year Est. Return
BMCM
Burns Matteson Capital Management Corning, New York $289M AUM 39.67% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return

Andera Partners's ABVX Position: Q3 2026 in Review

Andera Partners sold out of Abivax (ABVX) in Q3 2026, closing a stake of 78,125 shares — an estimated $10.4M sold.

Andera Partners first reported a position in ABVX in Q4 2025 and held it in 3 quarters. The position peaked at $10.5M in Q4 2025. 24 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Andera Partners reported no remaining Abivax position as of Q3 2026 after selling out during the quarter.
  • Andera Partners sold 78,125 Abivax shares in Q3 2026, an estimated $10.4M.
  • Andera Partners first reported a position in Abivax in Q4 2025 and held it in 3 quarters.
  • Andera Partners's Abivax position peaked at $10.5M in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Andera Partners's 13F filing for Q3 2026, filed 16 Oct 2026.